362 related articles for article (PubMed ID: 11207825)
1. Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease.
D'Andrea MR; Nagele RG; Wang HY; Peterson PA; Lee DH
Histopathology; 2001 Feb; 38(2):120-34. PubMed ID: 11207825
[TBL] [Abstract][Full Text] [Related]
2. Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains.
Nagele RG; D'Andrea MR; Lee H; Venkataraman V; Wang HY
Brain Res; 2003 May; 971(2):197-209. PubMed ID: 12706236
[TBL] [Abstract][Full Text] [Related]
3. Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease.
Nagele RG; D'Andrea MR; Anderson WJ; Wang HY
Neuroscience; 2002; 110(2):199-211. PubMed ID: 11958863
[TBL] [Abstract][Full Text] [Related]
4. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons.
D'Andrea MR; Nagele RG
Curr Pharm Des; 2006; 12(6):677-84. PubMed ID: 16472157
[TBL] [Abstract][Full Text] [Related]
5. Consistent immunohistochemical detection of intracellular beta-amyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex.
D'Andrea MR; Nagele RG; Wang HY; Lee DH
Neurosci Lett; 2002 Nov; 333(3):163-6. PubMed ID: 12429373
[TBL] [Abstract][Full Text] [Related]
6. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation.
Yilmazer-Hanke DM; Hanke J
Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378
[TBL] [Abstract][Full Text] [Related]
7. MAP-2 immunolabeling can distinguish diffuse from dense-core amyloid plaques in brains with Alzheimer's disease.
D'Andrea MR; Nagele RG
Biotech Histochem; 2002 Mar; 77(2):95-103. PubMed ID: 12083391
[TBL] [Abstract][Full Text] [Related]
8. Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease.
Chin J; Massaro CM; Palop JJ; Thwin MT; Yu GQ; Bien-Ly N; Bender A; Mucke L
J Neurosci; 2007 Mar; 27(11):2727-33. PubMed ID: 17360894
[TBL] [Abstract][Full Text] [Related]
9. Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer's disease.
Mandler M; Walker L; Santic R; Hanson P; Upadhaya AR; Colloby SJ; Morris CM; Thal DR; Thomas AJ; Schneeberger A; Attems J
Acta Neuropathol; 2014 Jul; 128(1):67-79. PubMed ID: 24861310
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of DNA fragmentation and beta-amyloid deposition in insular cortex and midfrontal gyrus from patients with Alzheimer's disease.
Colurso GJ; Nilson JE; Vervoort LG
Life Sci; 2003 Aug; 73(14):1795-803. PubMed ID: 12888118
[TBL] [Abstract][Full Text] [Related]
11. Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex.
Thal DR; Schultz C; Dehghani F; Yamaguchi H; Braak H; Braak E
Acta Neuropathol; 2000 Dec; 100(6):608-17. PubMed ID: 11078212
[TBL] [Abstract][Full Text] [Related]
12. Morphologically distinct types of amyloid plaques point the way to a better understanding of Alzheimer's disease pathogenesis.
D'Andrea MR; Nagele RG
Biotech Histochem; 2010 Apr; 85(2):133-47. PubMed ID: 20121465
[TBL] [Abstract][Full Text] [Related]
13. Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice.
Dong H; Martin MV; Chambers S; Csernansky JG
J Comp Neurol; 2007 Jan; 500(2):311-21. PubMed ID: 17111375
[TBL] [Abstract][Full Text] [Related]
14. Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease.
Cummings BJ; Pike CJ; Shankle R; Cotman CW
Neurobiol Aging; 1996; 17(6):921-33. PubMed ID: 9363804
[TBL] [Abstract][Full Text] [Related]
15. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
[TBL] [Abstract][Full Text] [Related]
16. Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model.
Reilly JF; Games D; Rydel RE; Freedman S; Schenk D; Young WG; Morrison JH; Bloom FE
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4837-42. PubMed ID: 12697936
[TBL] [Abstract][Full Text] [Related]
17. Identification of peptides that specifically bind Abeta1-40 amyloid in vitro and amyloid plaques in Alzheimer's disease brain using phage display.
Kang CK; Jayasinha V; Martin PT
Neurobiol Dis; 2003 Oct; 14(1):146-56. PubMed ID: 13678675
[TBL] [Abstract][Full Text] [Related]
18. Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions.
van Groen T; Liu L; Ikonen S; Kadish I
Neuroscience; 2003; 119(4):1185-97. PubMed ID: 12831872
[TBL] [Abstract][Full Text] [Related]
19. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments.
Kaneko I; Morimoto K; Kubo T
Neuroscience; 2001; 104(4):1003-11. PubMed ID: 11457586
[TBL] [Abstract][Full Text] [Related]
20. Heparan sulfate subdomains that are degraded by Sulf accumulate in cerebral amyloid ß plaques of Alzheimer's disease: evidence from mouse models and patients.
Hosono-Fukao T; Ohtake-Niimi S; Hoshino H; Britschgi M; Akatsu H; Hossain MM; Nishitsuji K; van Kuppevelt TH; Kimata K; Michikawa M; Wyss-Coray T; Uchimura K
Am J Pathol; 2012 May; 180(5):2056-67. PubMed ID: 22429964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
